Elequin Capital’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-53
| Closed | -$7.3K | – | 316 |
|
|
2024
Q4 | $7.3K | Buy |
53
+47
| +783% | +$6.47K | ﹤0.01% | 357 |
|
|
2024
Q3 | $896 | Buy |
+6
| New | +$896 | ﹤0.01% | 330 |
|
|
2024
Q2 | – | Sell |
-50
| Closed | -$7.56K | – | 202 |
|
|
2024
Q1 | $7.56K | Buy |
+50
| New | +$7.56K | ﹤0.01% | 126 |
|
|
2023
Q3 | – | Sell |
-44
| Closed | -$3.93K | – | 406 |
|
|
2023
Q2 | $3.93K | Buy |
+44
| New | +$3.93K | ﹤0.01% | 394 |
|
|
2022
Q4 | – | Sell |
-76
| Closed | -$8K | – | 626 |
|
|
2022
Q3 | $8K | Sell |
76
-37
| -33% | -$3.9K | ﹤0.01% | 285 |
|
|
2022
Q2 | $11K | Buy |
113
+94
| +495% | +$9.15K | ﹤0.01% | 229 |
|
|
2022
Q1 | $2K | Buy |
+19
| New | +$2K | ﹤0.01% | 252 |
|